1. Development of crescentic membranoproliferative glomerulonephritis after COVID-19 vaccination.
- Author
-
Göndör, Gabor, Ksiazek, Sara H, Regele, Heinz, Kronbichler, Andreas, Knechtelsdorfer, Maarten, and Säemann, Marcus D
- Subjects
COVID-19 vaccines ,COVID-19 ,GLOMERULONEPHRITIS ,KIDNEY glomerulus diseases ,NEPHRITIS - Abstract
Membranoproliferative glomerulonephritis (MPGN) comprises a histologic pattern of glomerular injury with different underlying diseases. Here we report on a 47-year-old female with rapidly progressive glomerulonephritis (RPGN) on top of a previously diagnosed idiopathic MPGN after receiving the first dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) mRNA vaccine. After aggressive immunosuppression her serum creatinine returned to normal values, along with reduction of proteinuria. Recently, numerous publications have reported an association of glomerular diseases with COVID-19 vaccination. Our case presents to the best of our knowledge the first occurrence of possible association of COVID-19 mRNA vaccination with a crescentic form of MPGN. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF